SoftBank leads $1.2 billion investment in diagnostics firm Invitae

SoftBank leads $1.2 billion investment in diagnostics firm Invitae

SoftBank leads $1.2 billion investment in diagnostics firm Invitae

FILE PHOTO: SoftBank Corp’s logo is pictured at a news conference in Tokyo, Japan, Feb. 4, 2021. REUTERS/Kim Kyung-Hoon/File Photo

(Reuters) – A group of investors including SoftBank Group Corp will invest $1.15 billion in Invitae Corp, the U.S. genetic diagnostics company said on Monday.

Reporting by Amruta Khandekar in Bengaluru; Editing by Shinjini Ganguli